CIK: 0001683689 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value ($000): $122,853 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Horizon Therapeutics Public Limited Company | 542,543 | $33,578 | 27.3% | $68.27 | — | SHS | G46188101 |
| IEFA | ISHARES TR | 389,922 | $20,537 | 16.7% | $72.87 | — | CORE MSCI EAFE | 46432F842 |
| — | JAMF HOLDING CORP | 623,443 | $13,815 | 11.2% | $35.90 | — | COM | 47074L105 |
| NEO | NeoGenomics Inc. | 1,539,113 | $13,252 | 10.8% | $23.81 | -58.3% | COM NEW | 64049M209 |
| FIVN | Five9, Inc. | 175,178 | $13,135 | 10.7% | $120.22 | -19.2% | COM | 338307101 |
| IEMG | ISHARES TR | 304,145 | $13,072 | 10.6% | $64.35 | — | CORE MSCI EMKT | 46434G103 |
| VCEL | Vericel Corporation | 552,963 | $12,829 | 10.4% | $15.89 | +71.7% | COM | 92346J108 |
| MITK | MITEK SYS INC | 254,255 | $2,329 | 1.9% | $18.28 | -45.1% | COM NEW | 606710200 |
| ISTB | ISHARES TR | 2,228 | $103 | 0.1% | $51.59 | — | CORE 1 5 YR USD | 46432F859 |
| IVV | ISHARES TR | 234 | $84 | 0.1% | $335.62 | — | CORE S&P500 ETF | 464287200 |
| IAGG | ISHARES TR | 862 | $42 | 0.0% | $56.04 | — | CORE INTL AGGR | 46435G672 |
| IMTB | ISHARES TR | 834 | $35 | 0.0% | $52.19 | — | CR 5 10 YR ETF | 46435G417 |
| IJH | ISHARES TR | 122 | $27 | 0.0% | $183.67 | — | CORE S&P MCP ETF | 464287507 |
| IJR | ISHARES TR | 169 | $15 | 0.0% | $72.46 | — | CORE S&P SCP ETF | 464287804 |